Editorial: Quality assurance in surgical oncology the EURECCA platform

European Journal of Surgical Oncology

Volumn 40, Issue 11, 2014, Pages 1387-1390

  Boelens, Petra G ^a   Audisio, Riccardo A ^b,c   Van De Velde, Cornelis J H ^a,d  

^a EURECCA   (Netherlands)

^b EURECCA Breast Group   (Netherlands)

^c ESSO   (United Kingdom)

^d ESSO and ECCO   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY IMAGE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CASE MIX; CHRONIC PAIN; CLINICAL TRIAL (TOPIC); COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE FREE SURVIVAL; GERIATRIC PATIENT; HUMAN; ONCOLOGY; ORGANIZATIONAL STRUCTURE; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PHYSICIAN; POSTOPERATIVE COMPLICATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RECTUM CANCER; REOPERATION; RESPONSIBILITY; REVIEW; SURGEON; SURGICAL ONCOLOGY; TREATMENT OUTCOME; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; NEOPLASMS; REGISTER; STANDARDS; SURGERY;

CLINICAL TRIALS AS TOPIC; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; SPECIALTIES, SURGICAL;

EID: 84922480949     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.08.478     Document Type: Editorial

References (10)

1. Breugom AJ, Boelens PG, van den Broek CB, et al. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 2014;25(8):1485-92.
2. Klaver YL, Lemmens VE, Creemers GJ, Rutten HJ, Nienhuijs SW, de Hingh IH. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 2011;22(10):2250-6.
3. de Steur WO, Henneman D, Allum WH, et al. Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI). Eur J Surg Oncol 2014;40(3):325-9.
4. van Gijn W, van den Broek CB, Mroczkowski P, et al. The EURECCA project: data items scored by European colorectal cancer audit registries. Eur J Surg Oncol 2012;38(6):467-71.
5. van de Water W, Kiderlen M, Bastiaannet E, et al. External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst 2014;106(4):dju051.
6. de Glas NA, van de Water W, Engelhardt EG, et al. Validity of adjuvant! Online program in older patients with breast cancer: a population-based study. Lancet Oncol 2014;15(7):722-9.
7. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12(6):575-82.
8. van den Broek CB, Kolfschoten NE, van Gijn W, et al. The EURECCA initiative - differences in treatment and short term outcome of rectal cancer. Eur J Cancer 2011;47(Suppl. 1):418.. [Ref Type: Abstract].
9. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15(1):23-34.
10. Siesling S, Kwast A, Gavin A, Baili P, Otter R. Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: results of EUROCHIP-3 survey. Int J Cancer 2013;132(12):2910-7.